Skip to main content
. 2019 Jun 2;10(14):3172–3178. doi: 10.7150/jca.30257

Table 1.

Patients and disease characteristics in the gastric cancer and according to DLL4 status.

Characteristic N=336 (%) DLL 4 (low) n=269 (80.1%) DLL 4 (high) n=67 (19.9%) p value
Age
Median (range), years 57 (28-77) 56 (28-77) 59 (33-77) 0.104
< 60 195 (58.0) 162 (60.2) 33 (49.3)
>60 141 (42.0) 107 (39.8) 34 (50.7)
Sex
Male 217 (64.6) 172 (63.9) 45 (67.2) 0.622
Female 119 (35.4) 97 (36.1) 22 (32.8)
Tumor Localization 0.296
Cardias 17 (5.1) 12 (4.5) 5 (7.5)
Body 159 (47.3) 133 (49.4) 26 (38.7)
Antrum 125 (37.2) 95 (35.3) 30 (44.8)
Whole/multiple 35 (10.4) 29 (10.8) 6 (9.0)
Histology 0.042
ADC,WD 5 (1.5) 2 (0.7) 3 (4.5)
ADC,MD 109 (32.4) 83 (30.9) 26 (38.8)
ADC,PD 147 (43.8) 119 (44.2) 28 (41.8)
Signet ring cell 75 (22.3) 65 (24.2) 10 (14.9)
Borrman classification
1 7 (2.1) 4 (1.5) 3 (4.5) 0.308
2 98 (29.2) 77 (28.6) 21 (31.3)
3 193 (57.4) 156 (58.0) 37 (55.2)
4 38 (11.3) 32 (11.9) 6 (9.0)
Lauren type
Intestinal 132 (39.2) 92 (34.2) 40 (59.7) < 0.001
Diffuse 189 (56.3) 164 (61.0) 25 (37.3)
Mixed 15 (4.5) 13 (4.8) 2 (3.0)
pT stage
1 8 (2.4) 7 (2.6) 1 (1.5) 0.511
2a 64 (19.0) 54 (20.1) 10 (14.9)
2b 158 (47.0) 120 (44.6) 38 (56.7)
3 95(28.3) 79 (29.4) 16 (23.9)
4 11 (3.3) 9 (3.3) 2 (3.0)
pN stage
0 13 (3.9) 11 (4.1) 2 (3.0) 0.130
1 202 (60.1) 165 (61.3) 37 (55.2)
2 87 (25.9) 71 (26.4) 16 (23.9)
3 34 (10.1) 22 (8.2) 12 (17.9)
Stage 0.037
II and IIIa 271 (80.7) 223 (82.9) 48 (71.6)
IIIb and IV 65 (19.3) 46 (17.1) 19 (28.4)
Cer-b status 0.018
negative 281 (83.6) 226(84.0) 55(82.1)
positive 18 (5.4) 9 (3.3) 9 (13.4)
unknown 37 (11.0) 34 (12.6) 3 (4.5)
Surgical resection 0.929
Subtotal 199 (59.2) 159 (59.1) 40 (59.7)
Total 137 (40.8) 110 (40.9) 27 (40.3)
Perineural invasion
No 177 (52.5) 143(50.3) 34 (50.7) 0.743
Yes 159 (47.5) 126 (47) 33 (49.3)
Lymphovascular invasion
No 106 (31.5) 86 (32.0) 20 (29.9) 0.738
Yes 230 (68.5) 183 (68.0) 47 (70.1)